These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17577924)

  • 1. Pretransplant treatment of donors with immunomodulators to control graft-versus-host disease (GVHD) in transplant recipients.
    Morecki S; Yacovlev E; Gelfand Y; Eizik O; Slavin S
    Exp Hematol; 2007 May; 35(5):748-56. PubMed ID: 17577924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators.
    Morecki S; Yacovlev E; Gelfand Y; Shabat Y; Slavin S
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):406-15. PubMed ID: 19285627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapy.
    Morecki S; Gelfand Y; Yacovlev E; Eizik O; Shabat Y; Slavin S
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):973-984. PubMed ID: 18721760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
    Pierce GE
    Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of allogeneic bone marrow and spleen cell transplantation in a murine model using ultraviolet-B light.
    Pamphilon DH; Alnaqdy AA; Godwin V; Preece AW; Wallington TB
    Blood; 1991 May; 77(9):2072-8. PubMed ID: 1826855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.
    Zhang C; Todorov I; Zhang Z; Liu Y; Kandeel F; Forman S; Strober S; Zeng D
    Blood; 2006 Apr; 107(7):2993-3001. PubMed ID: 16352808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of trifunctional bispecific antibodies to prevent graft versus host disease induced by allogeneic lymphocytes.
    Morecki S; Lindhofer H; Yacovlev E; Gelfand Y; Slavin S
    Blood; 2006 Feb; 107(4):1564-9. PubMed ID: 16234351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitivity and responsiveness to recombinant interleukin-2 of effector cells of graft vs. host disease and mixed lymphocyte reaction in mice.
    Stark J; Weiss L; Slavin S
    Isr J Med Sci; 1992 Nov; 28(11):767-72. PubMed ID: 1468887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PG27, an extract of Tripterygium wilfordii hook f, induces antigen-specific tolerance in bone marrow transplantation in mice.
    Chen Y; Zeng D; Schlegel PG; Fidler J; Chao NJ
    Blood; 2000 Jan; 95(2):705-10. PubMed ID: 10627483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of KRN7000 on induced graft-vs-host disease.
    Morecki S; Panigrahi S; Pizov G; Yacovlev E; Gelfand Y; Eizik O; Slavin S
    Exp Hematol; 2004 Jul; 32(7):630-7. PubMed ID: 15246159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of long-lasting antitumor immunity by concomitant cell therapy with allogeneic lymphocytes and trifunctional bispecific antibody.
    Morecki S; Lindhofer H; Yacovlev E; Gelfand Y; Ruf P; Slavin S
    Exp Hematol; 2008 Aug; 36(8):997-1003. PubMed ID: 18495330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of deoxyspergualin on graft-versus-host disease and graft- versus-leukemia in mice.
    Weiss L; Reich S; Slavin S
    Bone Marrow Transplant; 1996 May; 17(5):789-92. PubMed ID: 8733699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of oral tolerance in bone marrow transplantation recipients suppresses graft-versus-host disease in a semiallogeneic mouse model.
    Nagler A; Ohana M; Alper R; Doviner V; Sherman Y; Rabbani E; Engelhardt D; Ilan Y
    Bone Marrow Transplant; 2003 Aug; 32(4):363-9. PubMed ID: 12900772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recipient type-specific engineered regulatory T cells prevent graft-vs-host disease after allogeneic bone marrow transplantation in mice.
    Chen C; Cao J; Zeng L; Li Y; Wang D; Xu K
    Transplant Proc; 2011 Jun; 43(5):2041-8. PubMed ID: 21693322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of CD4+ and CD8+ cells in normal F1 hybrid host in the resistance to lethal graft-versus-host disease induction by transfer of parent spleen cells.
    Kitajima T; Iwashiro M; Kuribayashi K; Imamura S
    Immunol Lett; 1994 Jun; 40(3):207-10. PubMed ID: 7959888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice.
    Zeis M; Steinmann J; Petrela E; Hartung G; Schmitz N; Uharek L
    Bone Marrow Transplant; 2001 Feb; 27(3):279-85. PubMed ID: 11277175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model.
    Ilan Y; Gotsman I; Pines M; Beinart R; Zeira M; Ohana M; Rabbani E; Engelhardt D; Nagler A
    Blood; 2000 Jun; 95(11):3613-9. PubMed ID: 10828052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glucocorticoid amplifies IL-2-induced selective expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation.
    Xie Y; Wu M; Song R; Ma J; Shi Y; Qin W; Jin Y
    Acta Biochim Biophys Sin (Shanghai); 2009 Sep; 41(9):781-91. PubMed ID: 19727527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.